Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Neurogene (NGNE) Return on Capital Employed (2019 - 2025)

Historic Return on Capital Employed for Neurogene (NGNE) over the last 4 years, with Q3 2025 value amounting to 0.35%.

  • Neurogene's Return on Capital Employed rose 1400.0% to 0.35% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.35%, marking a year-over-year increase of 1400.0%. This contributed to the annual value of 0.31% for FY2024, which is N/A changed from last year.
  • According to the latest figures from Q3 2025, Neurogene's Return on Capital Employed is 0.35%, which was up 1400.0% from 0.33% recorded in Q2 2025.
  • Neurogene's Return on Capital Employed's 5-year high stood at 0.29% during Q1 2025, with a 5-year trough of 1.02% in Q2 2023.
  • Its 3-year average for Return on Capital Employed is 0.46%, with a median of 0.39% in 2024.
  • Per our database at Business Quant, Neurogene's Return on Capital Employed soared by 6300bps in 2024 and then soared by 200bps in 2025.
  • Over the past 3 years, Neurogene's Return on Capital Employed (Quarter) stood at 0.42% in 2023, then rose by 16bps to 0.35% in 2024, then grew by 0bps to 0.35% in 2025.
  • Its Return on Capital Employed stands at 0.35% for Q3 2025, versus 0.33% for Q2 2025 and 0.29% for Q1 2025.